CoChat

Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies

Open access
Stoll, Gautier, Bindea, Gabriela, Mlecnik, Bernhard, Galon, Jérôme, Zitvogel, Laurence, Kroemer, Guido · 2015 · Oncotarget
Cited by 41

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

// Gautier Stoll 1,2,3,4 , Gabriela Bindea 1,3,4 , Bernhard Mlecnik 1,3,4 , Jérôme Galon 1,3,4 , Laurence Zitvogel 5,6,7,8,9 and Guido Kroemer 1,2,3,4,5,10 1 Université Paris Descartes, Sorbonne Paris Cité, Paris, France 2 Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France 3 Institut National de la Santé et de la Recherche Médicale, Paris, France 4 Université Pierre et Marie Curie, Paris, France 5 Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France 6 Institut National de la Santé et de la Recherche Médicale, Equipe labellisée Ligue Nationale Contre le Cancer, Villejuif, France 7 Institut Gustave Roussy Cancer Campus, Villejuif, France 8 Faculty of Medicine, University of Paris Sud, Kremlin-Bicêtre, France 9 Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Villejuif, France 10 Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France Correspondence to: Guido Kroemer, email: // Keywords : meta-analysis of microarrays, breast cancer, colorectal carcinoma, melanoma, non-small cell lung cancer Received : April 30, 2015 Accepted : May 09, 2015 Published : May 19, 2015 Abstract Anticancer immunosurveillance is one of the major endogenous breaks of tumor progression. Here, we analyzed gene expression pattern indicative of the presence of distinct leukocyte subtypes within four cancer types (breast cancer, colorectal carcinoma, melanoma, and non-small cell lung cancer) and 20 different microarray datasets corresponding to a total of 3471 patients. Multiple metagenes reflecting the presence of such immune cell subtypes were highly reproducible across distinct cohorts. Nonetheless, there were sizable differences in the correlation patterns among such immune-relevant metagenes across distinct malignancies. The reproducibility of the correlations among immune-relevant metagenes was highest in breast cancer (followed by colorectal cancer, non-small cell lung cancer and melanoma), reflecting the fact that mammary carcinoma has an intrinsically better prognosis than the three other malignancies. Among breast cancer patients, we found that the expression of a lysosomal enzyme-related metagene centered around ASAH1 (which codes for N-acylsphingosine amidohydrolase-1, also called acid ceramidase) exhibited a higher correlation with multiple immune-relevant metagenes in patients that responded to neoadjuvant chemotherapy than in non-responders. Altogether, this meta-analysis revealed novel organ-specific features of the immune infiltrate in distinct cancer types, as well as a strategy for defining new prognostic biomarkers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.4180

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 41

Metadata

Authors
Stoll, G., Bindea, G., Mlecnik, B., Galon, J., Zitvogel, L., & Kroemer, G.
Venue
Oncotarget
Published
2015-05-19
Volume
6
Issue
14
Pages
11894-11909
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1907865033
Cited by
41
References
6
FWCI
1.03
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.